The Company respectfully believes that the information set forth in Item 13(a) of Schedule 14A is not required with respect to Proposal No. 7. The Company is submitting Proposal No. 7 in order to comply with NASDAQ Listing Rules 5635(a) and (d), which require stockholder approval of certain transactions that result in the issuance of 20% or more of the outstanding voting power or shares of common stock outstanding before the issuance of stock or securities.
Pursuant to Instruction 1 of Item 13(a) of Schedule 14A, “information is not deemed material where the matter to be acted upon is the authorization or issuance of common stock, otherwise than in an exchange, merger, consolidation, acquisition or similar transaction.” Proposal No. 7 is seeking approval of the issuance of 20% or more of common stock that may be issuable in (x) a private placement of Quinpario Common Stock in connection with the Backstop Commitment, (y) upon conversion of 45,000 shares of Series A Convertible Preferred Stock into Quinpario Common Stock issued in a private placement, and (z) a subsequent conversion of such additional shares of Series A Convertible Preferred Stock into Quinpario Common Stock that are received as dividends, none of which are to be issued in the acquisition of Jason. Proposal No. 7 is not seeking approval of the issuance of any senior security. As such, the Company respectfully submits that the information required in Item 13(a) is not required in the Proxy Statement, as the matter being acted upon is the Company’s ability to issue shares of common stock in a private placement.
* * * * *
We would be pleased to answer any questions you may have with regard to the Company’s response to the Staff Letter. Please direct any such questions to the undersigned by telephone at (212) 451-2252, by email at kschlesinger@olshanlaw.com or by facsimile at (212) 451-2222.
Thank you for your assistance.
Sincerely, |
|
/s/ Kenneth A. Schlesinger |
|
Kenneth A. Schlesinger |
cc: Paul J. Berra III